Dipyridamole

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Dipyridamole belongs to the group of glycoprotein IIb/IIIa receptor blockers.

Pharmacodynamics (Effect)This section has been translated automatically.

Dipyridamole reduces the release of intrathrombocytic ionized calcium and decreases the calcium influx. In addition, the supply of ADP is reduced, thus inhibiting ADP-mediated platelet aggregation. It also inhibits the uptake of adenosine into the endothelium, platelets and erythrocytes. It also blocks cyclo-GMP and cyclo-AMP phosphodiesterases.

Further effects of dipyridamole are the stimulation of the synthesis and release of prostacyclin and an antagonization of the coagulation-promoting effect of the subendothelial structures, especially via the nitric oxide effect.

IndicationThis section has been translated automatically.

Dipyridamole is used in combination with ASA for secondary prevention of TIA or apoplexy.

Dosage and method of useThis section has been translated automatically.

3 x 75 mg p.o.; in combination with ASS: Aggrenox (200 mg + 25 mg). Dosage: 2 x 1 tablet,

PreparationsThis section has been translated automatically.

Curantyl N ®.

LiteratureThis section has been translated automatically.

  1. HA Neumann (2014) The coagulation system. ABW-Scientific Publisher GmbH Berlin

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer